Kentucky Retirement Systems Insurance Trust Fund Decreases Position in Henry Schein, Inc. (NASDAQ:HSIC)

Kentucky Retirement Systems Insurance Trust Fund cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 7.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,288 shares of the company’s stock after selling 364 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Henry Schein were worth $324,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. McGlone Suttner Wealth Management Inc. purchased a new stake in Henry Schein during the fourth quarter valued at approximately $39,000. Mather Group LLC. purchased a new position in Henry Schein in the 1st quarter worth $97,000. Palisade Asset Management LLC purchased a new position in shares of Henry Schein during the 1st quarter valued at about $113,000. Benjamin F. Edwards & Company Inc. raised its stake in shares of Henry Schein by 37.8% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock valued at $114,000 after buying an additional 416 shares during the last quarter. Finally, Covestor Ltd increased its stake in shares of Henry Schein by 12.8% in the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock valued at $114,000 after purchasing an additional 171 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Down 0.7 %

Shares of HSIC traded down $0.49 during midday trading on Monday, hitting $71.82. The company had a trading volume of 483,779 shares, compared to its average volume of 1,101,949. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63. The company’s 50 day moving average price is $68.08 and its 200 day moving average price is $71.83. The stock has a market cap of $9.20 billion, a price-to-earnings ratio of 24.43, a PEG ratio of 1.78 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. During the same quarter in the prior year, the firm earned $1.21 EPS. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, equities research analysts predict that Henry Schein, Inc. will post 5.16 EPS for the current year.

Analysts Set New Price Targets

Several research firms have commented on HSIC. UBS Group cut their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Robert W. Baird raised Henry Schein from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $81.00 to $92.00 in a research report on Monday, July 22nd. Evercore ISI cut their price objective on Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Finally, Barrington Research reissued an “outperform” rating and issued a $92.00 target price on shares of Henry Schein in a report on Friday, July 5th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $81.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.